In the hepatocytes, LPL is synthesized at fetal liver, then turned dim soon after birth [25], similar to the expression pattern of AFP, which is the first identified target of ZHX2 and promotes HCC development [12, 33]. The gene discussed is AFP; the disease is hepatocellular carcinoma.